Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | IL-1 alpha | 100 | ng/mL | 2 | MMP-3 | 2048.0 | 83 | ||||
N2645 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 2 | MMP-3 | 1889.0 | 58 | |
N2645 | IL-1 alpha | 100 | ng/mL | 2 | MMP-3 | 1799.5 | 50 | ||||
RA2708 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 2 | MMP-3 | 26186.0 | 49 | |
RA2708 | IL-1 alpha | 100 | ng/mL | 2 | MMP-3 | 24545.0 | 39 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 2 | MMP-3 | 64.0 | 55 | |
RA2159 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | MMP-3 | 60.0 | 30 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 2 | MMP-3 | 31.0 | 50 | |
N2645 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | MMP-3 | 121.0 | 50 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 2 | MMP-3 | 145.0 | 75 | |
RA2708 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | MMP-3 | 144.0 | 50 | |
RA2159 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 2 | MMP-3 | 93.0 | 61 | |
RA2159 | Poly(I:C) | 2 | ug/mL | 2 | MMP-3 | 73.0 | 60 | ||||
N2645 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 2 | MMP-3 | 44.0 | 54 | |
N2645 | Poly(I:C) | 2 | ug/mL | 2 | MMP-3 | 40.0 | 43 | ||||
RA2708 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 2 | MMP-3 | 1108.0 | 45 | |
RA2708 | Poly(I:C) | 2 | ug/mL | 2 | MMP-3 | 581.0 | 38 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | 2 | MMP-3 | 69.0 | 55 | ||||
RA2159 | IKK16 | 2.0 | uM | 2 | MMP-3 | 62.0 | 65 | ||||
N2645 | 5z-7-oxozeaenol | 0.6 | uM | 2 | MMP-3 | 51.0 | 56 | ||||
N2645 | IKK16 | 2.0 | uM | 2 | MMP-3 | 38.0 | 80 | ||||
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | 2 | MMP-3 | 173.0 | 37 | ||||
RA2708 | IKK16 | 2.0 | uM | 2 | MMP-3 | 87.0 | 23 | ||||
RA2159 | Tofacitinib | 0.3 | uM | 2 | MMP-3 | 60.0 | 23 | ||||
RA2159 | 2 | MMP-3 | 62.0 | 41 |